AMAG PHARMACEUTICALS, INC. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.87 | 24,000 | 116,880 | 348,000 | 324 K to 348 K (+7.41 %) |
| Mar 18 2020 | AVM | AMAG PHARMACEUTICA ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 4.87 | 24,000 | 116,880 | 348,000 | 324 K to 348 K (+7.41 %) |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Option Exercise | A | 7.27 | 45,000 | 327,150 | 45,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Grant | A | 0.00 | 30,000 | 0 | 98,659 | 68.7 K to 98.7 K (+43.69 %) |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | A | 7.27 | 17,000 | 123,590 | 17,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Grant | A | 0.00 | 13,000 | 0 | 28,234 | 15.2 K to 28.2 K (+85.34 %) |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Option Exercise | A | 7.27 | 35,000 | 254,450 | 35,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Grant | A | 0.00 | 25,000 | 0 | 92,244 | 67.2 K to 92.2 K (+37.18 %) |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Commercial Of ... | Option Exercise | A | 7.27 | 40,000 | 290,800 | 40,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Commercial Of ... | Grant | A | 0.00 | 25,000 | 0 | 78,209 | 53.2 K to 78.2 K (+46.98 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Commercial Of ... | Payment of Exercise | F | 7.75 | 924 | 7,161 | 53,209 | 54.1 K to 53.2 K (-1.71 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Payment of Exercise | F | 7.75 | 358 | 2,775 | 15,234 | 15.6 K to 15.2 K (-2.30 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | HEIDEN WILLIAM K | President & CEO | Payment of Exercise | F | 7.75 | 4,451 | 34,495 | 424,612 | 429.1 K to 424.6 K (-1.04 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | CBO, General Counse ... | Payment of Exercise | F | 7.75 | 1,138 | 8,820 | 67,244 | 68.4 K to 67.2 K (-1.66 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Payment of Exercise | F | 7.75 | 1,021 | 7,913 | 68,659 | 69.7 K to 68.7 K (-1.47 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Krop Julie | Chief Medical Offic ... | Payment of Exercise | F | 7.75 | 1,333 | 10,331 | 73,044 | 74.4 K to 73 K (-1.79 %) |